You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 18, May 14, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Screening Strategies for Cancer

Implications and Results

Bruce A. Chabner, MD; Frank G. Haluska, MD, PhD; James A. Talcott, MD

JAMA. 1997;277(18):1475-1476.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the fight against cancer we seem to have turned the corner. For the first time comprehensive surveys indicate a small but steady decline in cancer mortality rates over a 5-year period (1990 to 1995).1 These improvements have resulted from advances in cancer prevention, early diagnosis, and treatment. The contribution of treatment is most easily quantified for children with cancer, most of whom are treated at cancer centers and on research protocols. For adults, improvements in survival suggest a significant impact of treatment in certain solid tumors, such as breast cancer, and in the hematologic malignancies.

Progress in prevention and screening is somewhat easier to document. Antismoking efforts have had some success among adult males, although women and teens seem less influenced by these interventions. In the field of cancer screening, Papanicolaou tests have dramatically lowered the incidence of cervical cancer in screened populations. Similarly, mammography is effective in . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Hematology/Oncology, Massachusetts General Hospital, and Dana Farber/Partners CancerCare, Boston.


Footnotes

Reprints: Bruce A. Chabner, MD, Massachusetts General Hospital, 100 Blossom St, Cox 640, Boston, MA 02114.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.